For Surgery

Lyophilized fibrin sealant designed to stop severe bleeding
   

Effective control
of bleeding in surgery

ClotBlockŪ is a second-generation lyophilized fibrin sealant shaped as a compressed sponge, patch or gauze in various sizes and shapes to adapt to every surgical need. It bypasses fibrinogen cleavage, producing a strong fibrin polymer. 

Indication

Control of intraopertive bleeding. Can be used as an adjunct to hemostasis or as primary treatment; no stitches or sutures needed. ClotBlock provides a flexible choice where arterial hemostasis is critically important.

 
     
   

Spleen laceration

 

Partial
nephrectomy

 
   

Mode of Action

ClotBlock's fibrin-ready technology stanches the flow of blood from a lesion by gently pressing it against the surface of the organ for a few seconds. Produced as a solid cake, a flexible gauze, a small ball or catheter-size cylinder, ClotBlock offers flexibility to the surgeon by conforming to the contour of the organ.

Advantages

ClotBlock is a plasmin-depleted, aprotinin-free fibrin presenting no risk of autoimmune reaction, and minimal risk of anaphylactic or systemic reaction to human blood products.
ClotBlock fibrin products can be kept at room temperature.
 

Developed with the support of the Defense Advanced Research Project Agency (DARPA), The National Heart, Blood, and Lung Institute (NHLBI) of the National Institutes of Health (NIH); The US Army Medical Research and Materiel Command (USAMRMC); the Maryland Technology Development Corporation (TEDCO ), Johnson & Johnson, and the University of Maryland